Refine Results
  1. "Michel Sadelain"
Formats
  1. Journal Article (246)
  2. Meeting Abstract (235)
  3. Conference Paper (3)
  4. Book Section (2)
Groups
  1. Center for Hematologic Malignancies (486)
  2. Hematologic Malignancies Research (486)
  3. Molecular Pharmacology and Chemistry Program Faculty (486)
  4. Sloan Kettering Institute Faculty (486)
  5. Hematologic Oncology, Division of (465)
  6. Adult Leukemia (104)

More Groups

People
  1. Michel Sadelain (486)
  2. Isabelle Riviere (164)
  3. Renier Brentjens (101)
  4. Xiuyan Wang (69)
  5. Jae Park (55)
  6. Richard O'Reilly (33)

More People

Years
  1. 2020 (2)
  2. 2019 (20)
  3. 2018 (28)
  4. 2017 (26)
  5. 2016 (27)
  6. 2015 (30)

More Years

Publications
  1. Blood (107)
  2. Molecular Therapy (47)
  3. Cancer Research (19)
  4. Journal of Clinical Oncology (18)
  5. Nature Biotechnology (13)
  6. Journal of Thoracic Oncology (12)

More Publications

Publishers
  1. American Society of Hematology (107)
  2. Nature Publishing Group (98)
  3. Elsevier Inc. (45)
  4. American Association for Cancer Research (38)
  5. American Society of Clinical Oncology (19)
  6. Elsevier Science, Inc. (14)

More Publishers

Results (486)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Durable remission following "off-the-shelf" chimeric antigen receptor (CAR) T-cells in patients with relapse/refractory (R/R) B-cell malignancies
    Meeting Abstract

    Curran, K. J.; Sauter, C. S.; Kernan, N. A.; Prockop, S. E.; Boulad, F.; Perales, M.; Giralt, S. A.; Riviere, I.; Wang, X.; Boelens, J. J.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Potent synergy between combination of chimeric antigen receptor (CAR) therapy targeting CD19 in conjunction with dendritic cell (DC)/tumor fusion vaccine in hematological malignancies
    Meeting Abstract

    Capelletti, M.; Liegel, J.; Themeli, M.; Mutis, T.; Stroopinsky, D.; Orr, S.; Torres, D.; Morin, A.; Gunset, G.; Ghiasuddin, H.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL
    Journal Article

    Curran, K. J.; Margossian, S. P.; Kernan, N. A.; Silverman, L. B.; Williams, D. A.; Shukla, N.; Kobos, R.; Forlenza, C. J.; Steinherz, P.; Prockop, S.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Clinical utilization of chimeric antigen receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL) - An expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Transplantation (ASBMT)
    Journal Article

    Kansagra, A. J.; Frey, N. V.; Bar, M.; Laetsch, T. W.; Carpenter, P. A.; Savani, B. N.; Heslop, H. E.; Bollard, C. M.; Komanduri, K. V.; Gastineau, D. A.; more...
    Bone Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Impact of bridging chemotherapy on clinical outcome of CD19 CAR T therapy in adult ALL
    Meeting Abstract

    Perica, K.; Flynn, J.; Curran, K. J.; Wang, X.; Halton, E.; Diamonte, C.; Pineda, J.; Bernal, Y.; Gonen, M.; Riviere, I.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Regional delivery of mesothelin-targeted CAR T cells for pleural cancers: Safety and preliminary efficacy in combination with anti-PD-1 agent
    Meeting Abstract

    Adusumilli, P. S.; Zauderer, M. G.; Rusch, V. W.; O'Cearbhaill, R.; Zhu, A.; Ngai, D.; McGee, E.; Chintala, N.; Messinger, J.; Cheema, W.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A phase I clinical trial of malignant pleural disease treated with regionally delivered autologous mesothelin-targeted CAR T cells: Safety and efficacy
    Meeting Abstract

    Adusumilli, P. S.; Zauderer, M. G.; Rusch, V. W.; O'Cearbhaill, R. E.; Zhu, A.; Ngai, D. A.; McGee, E.; Chintala, N. K.; Messinger, J. C.; Vincent, A.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Generation of novel single cell-derived engineered master pluripotent cell line as a renewable source for off-the-shelf TCR-less CAR T cells in support of first-of-kind clinical trial
    Meeting Abstract

    Abujarour, R.; Lai, Y. S.; Pribadi, M.; Lee, T.; Robinson, M.; Ruller, C.; Van der Stegen, S.; Wang, X.; Stefanski, J.; Zhen, J.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Conditioning prior to CD19-specific CAR (19-28Z) T cells predicts response and survival in pediatric relapse/refractory (R/R) B-ALL
    Meeting Abstract

    Curran, K.; Margossian, S.; Kernan, N.; Prockop, S.; Boulad, F.; Cancio, M.; Szenes, V.; Kung, A.; Boelens, J. J.; O'Reilly, R.; more...
    Bone Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • CD19 CAR T cells following autologous transplantation in poor-risk relapsed and refractory B-cell non-Hodgkin lymphoma
    Journal Article

    Sauter, C. S.; Senechal, B.; Rivière, I.; Ni, A.; Bernal, Y.; Wang, X.; Purdon, T.; Hall, M.; Singh, A. N.; Szenes, V. Z.; more...
    Blood (2019)

    Fulltext@MSK | Save